Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2023

Open Access 01-12-2023 | Ketoacidosis | Research

The effectiveness of blood glucose and blood ketone measurement in identifying significant acidosis in diabetic ketoacidosis patients

Authors: Eric S. Kilpatrick, Alexandra E. Butler, Sawsan Saeed, Naji Alamuddin, Stephen L. Atkin, David B. Sacks

Published in: Diabetology & Metabolic Syndrome | Issue 1/2023

Login to get access

Abstract

Background

Patients with diabetic ketoacidosis (DKA), a potentially fatal complication of type 1 diabetes, have hyperglycemia, ketonemia and metabolic acidosis. Blood glucose and blood ketone results are often used to triage patients with suspected DKA. This study aimed to establish how effective blood glucose and blood ketone (beta-hydroxybutyrate, BOHB) measurements are in identifying patients with significant acidosis and sought to validate existing diagnostic BOHB thresholds.

Methods

Initial Emergency Department results on 161 presumptive DKA episodes in 95 patients (42 F, 53 M, age range 14–89 years) containing a complete dataset of D (glucose), K (BOHB) and A (Bicarbonate [HCO3] and pH) results.

Results

Blood glucose correlated poorly with BOHB (r = 0.28 p = 0.0003), pH (r= -0.25, p = 0.002) and HCO3 (r= -0.17, p = 0.04). BOHB, though better, was still limited in predicting pH (r = -0.44, p < 0.0001) and HCO3 (r = -0.49, p < 0.0001). A HCO3 of 18mmol/L equated to a BOHB concentration of 4.3mmol/L, whilst a HCO3 of 15mmol/L equated to a BOHB of 4.7mmol/L. Of the 133 of 161 events with HCO3 < 18mmol/L, 22 were not hyperglycemic (> 13.9mmol/L, n = 8), ketonemic (≤ 3mmol/L, n = 9) or either (n = 5).

Conclusions

The commonly employed BOHB diagnostic cutoff of 3mmol/L could not be verified. Since acid-base status was poorly predicted by both glucose and BOHB, this highlights that, regardless of their results, pH and/or HCO3 should also be tested in any patient suspected of DKA.
Literature
2.
go back to reference Kilpatrick ES, Butler AE, Ostlundh L, Atkin SL, Sacks DB. Controversies around the measurement of blood Ketones to diagnose and manage Diabetic Ketoacidosis. Diabetes Care. 2022;45(2):267–72.CrossRefPubMedPubMedCentral Kilpatrick ES, Butler AE, Ostlundh L, Atkin SL, Sacks DB. Controversies around the measurement of blood Ketones to diagnose and manage Diabetic Ketoacidosis. Diabetes Care. 2022;45(2):267–72.CrossRefPubMedPubMedCentral
3.
go back to reference Dhatariya K. The management of Diabetic ketoacidosis in adults. London, UK: Joint British Diabetes Societies for Inpatient Care. Contract No.: JBDS 02; 2021. Dhatariya K. The management of Diabetic ketoacidosis in adults. London, UK: Joint British Diabetes Societies for Inpatient Care. Contract No.: JBDS 02; 2021.
4.
go back to reference Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018;19(Suppl 27):155–77.CrossRefPubMed Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes. 2018;19(Suppl 27):155–77.CrossRefPubMed
5.
go back to reference Rosenstock J, Ferrannini E. Euglycemic Diabetic Ketoacidosis: a predictable, detectable, and Preventable Safety concern with SGLT2 inhibitors. Diabetes Care. 2015;38(9):1638–42.CrossRefPubMed Rosenstock J, Ferrannini E. Euglycemic Diabetic Ketoacidosis: a predictable, detectable, and Preventable Safety concern with SGLT2 inhibitors. Diabetes Care. 2015;38(9):1638–42.CrossRefPubMed
6.
go back to reference Agiostratidou G, Anhalt H, Ball D, Blonde L, Gourgari E, Harriman KN, et al. Standardizing clinically meaningful outcome measures beyond HbA(1c) for type 1 diabetes: a Consensus Report of the American Association of Clinical Endocrinologists, the American Association of diabetes educators, the american Diabetes Association, the Endocrine Society, JDRF International, the Leona M. and Harry B. Helmsley charitable trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care. 2017;40(12):1622–30.CrossRefPubMedPubMedCentral Agiostratidou G, Anhalt H, Ball D, Blonde L, Gourgari E, Harriman KN, et al. Standardizing clinically meaningful outcome measures beyond HbA(1c) for type 1 diabetes: a Consensus Report of the American Association of Clinical Endocrinologists, the American Association of diabetes educators, the american Diabetes Association, the Endocrine Society, JDRF International, the Leona M. and Harry B. Helmsley charitable trust, the Pediatric Endocrine Society, and the T1D Exchange. Diabetes Care. 2017;40(12):1622–30.CrossRefPubMedPubMedCentral
7.
go back to reference Wallace TM, Meston NM, Gardner SG, Matthews DR. The hospital and home use of a 30-second hand-held blood ketone meter: guidelines for clinical practice. Diabet Med. 2001;18(8):640–5.CrossRefPubMed Wallace TM, Meston NM, Gardner SG, Matthews DR. The hospital and home use of a 30-second hand-held blood ketone meter: guidelines for clinical practice. Diabet Med. 2001;18(8):640–5.CrossRefPubMed
8.
go back to reference Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, et al. Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008;31(4):643–7.CrossRefPubMed Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, et al. Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008;31(4):643–7.CrossRefPubMed
9.
go back to reference Hirobata T, Inaba H, Kaido Y, Kosugi D, Itoh S, Matsuoka T, et al. Serum ketone body measurement in patients with diabetic ketoacidosis. Diabetol Int. 2022;13(4):624–30.CrossRefPubMedPubMedCentral Hirobata T, Inaba H, Kaido Y, Kosugi D, Itoh S, Matsuoka T, et al. Serum ketone body measurement in patients with diabetic ketoacidosis. Diabetol Int. 2022;13(4):624–30.CrossRefPubMedPubMedCentral
10.
go back to reference Dhatariya KK, Umpierrez GE. Guidelines for management of diabetic ketoacidosis: time to revise? Lancet Diabetes Endocrinol. 2017;5(5):321–3.CrossRefPubMed Dhatariya KK, Umpierrez GE. Guidelines for management of diabetic ketoacidosis: time to revise? Lancet Diabetes Endocrinol. 2017;5(5):321–3.CrossRefPubMed
11.
go back to reference Diabetes (type. 1 and type 2) in children and young people: diagnosis and management.: National Institute for Health and Care Excellence guidance 2021. Contract No.: NG18. Diabetes (type. 1 and type 2) in children and young people: diagnosis and management.: National Institute for Health and Care Excellence guidance 2021. Contract No.: NG18.
13.
go back to reference Soto-Mota A, Norwitz NG, Evans RD, Clarke K. Exogenous d-beta-hydroxybutyrate lowers blood glucose in part by decreasing the availability of L-alanine for gluconeogenesis. Endocrinol Diabetes Metab. 2022;5(1):e00300.CrossRefPubMed Soto-Mota A, Norwitz NG, Evans RD, Clarke K. Exogenous d-beta-hydroxybutyrate lowers blood glucose in part by decreasing the availability of L-alanine for gluconeogenesis. Endocrinol Diabetes Metab. 2022;5(1):e00300.CrossRefPubMed
14.
go back to reference Ceriotti F, Kaczmarek E, Guerra E, Mastrantonio F, Lucarelli F, Valgimigli F, et al. Comparative performance assessment of point-of-care testing devices for measuring glucose and ketones at the patient bedside. J Diabetes Sci Technol. 2015;9(2):268–77.CrossRefPubMed Ceriotti F, Kaczmarek E, Guerra E, Mastrantonio F, Lucarelli F, Valgimigli F, et al. Comparative performance assessment of point-of-care testing devices for measuring glucose and ketones at the patient bedside. J Diabetes Sci Technol. 2015;9(2):268–77.CrossRefPubMed
15.
go back to reference Dhatariya KK, Nunney I, Higgins K, Sampson MJ, Iceton G. National survey of the management of Diabetic Ketoacidosis (DKA) in the UK in 2014. Diabet Med. 2016;33(2):252–60.CrossRefPubMed Dhatariya KK, Nunney I, Higgins K, Sampson MJ, Iceton G. National survey of the management of Diabetic Ketoacidosis (DKA) in the UK in 2014. Diabet Med. 2016;33(2):252–60.CrossRefPubMed
Metadata
Title
The effectiveness of blood glucose and blood ketone measurement in identifying significant acidosis in diabetic ketoacidosis patients
Authors
Eric S. Kilpatrick
Alexandra E. Butler
Sawsan Saeed
Naji Alamuddin
Stephen L. Atkin
David B. Sacks
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2023
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-023-01176-w

Other articles of this Issue 1/2023

Diabetology & Metabolic Syndrome 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.